JOURNAL OF NEPHROLOGY, vol.32, no.1, pp.83-91, 2019 (SCI-Expanded)
BackgroundThe prominent features of autosomal dominant polycystic kidney disease (ADPKD) are early development of hypertension, chronic kidney disease and cardiovascular problems. Thus, we aimed to investigate the role of endothelin, a vascular biomarker, in the clinical course of ADPKD, including renal and cardiovascular survival.